Large-scale cerebrospinal fluid proteomics identifies diagnostic biomarker candidates across the clinico-pathological continuum of frontotemporal lobar degeneration
Rowan Saloner, Louisa Cornelis, Joshua D. Downer, Connor D. Dietz, Brandon Chan, Michelle Hughes, Molly Olzinski, Yann Cobigo, Argentina Lario‐Lago, Hilary W. Heuer, Karly Alex Cody, Madeline Wood, Katheryn A Q Cousins, David A. Wolk, Edward B. Lee, , Adam L. Boxer
The paper identifies potential diagnostic biomarkers for frontotemporal lobar degeneration subtypes using cerebrospinal fluid proteomics.
bioRxiv · Oct 8, 2026 · PreprintNeuroscience